Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 1c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q1 EPS of $0.07, $0.01 better than the analyst estimate of $0.06.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• BofA maintains underperform ratings on six BDC stocks
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)